DE3788982D1 - Trans-6-[2-(N-heteroaryl)-3,5-disubstituiertes)pyrazol-4-yl)-ethyl] oder -ethenyl]tetrahydro-4-hydroxypyran-2-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung. - Google Patents

Trans-6-[2-(N-heteroaryl)-3,5-disubstituiertes)pyrazol-4-yl)-ethyl] oder -ethenyl]tetrahydro-4-hydroxypyran-2-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung.

Info

Publication number
DE3788982D1
DE3788982D1 DE87109726T DE3788982T DE3788982D1 DE 3788982 D1 DE3788982 D1 DE 3788982D1 DE 87109726 T DE87109726 T DE 87109726T DE 3788982 T DE3788982 T DE 3788982T DE 3788982 D1 DE3788982 D1 DE 3788982D1
Authority
DE
Germany
Prior art keywords
hydroxypyran
pyrazol
ethenyl
disubstituted
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87109726T
Other languages
English (en)
Other versions
DE3788982T2 (de
Inventor
Bruce David Roth
Drago Robert Sliskovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE3788982D1 publication Critical patent/DE3788982D1/de
Publication of DE3788982T2 publication Critical patent/DE3788982T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE3788982T 1986-07-07 1987-07-06 Trans-6-[2-(N-heteroaryl)-3,5-disubstituiertes)pyrazol-4-yl)-ethyl] oder -ethenyl]tetrahydro-4-hydroxypyran-2-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung. Expired - Fee Related DE3788982T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88232786A 1986-07-07 1986-07-07
US07/048,473 US4808621A (en) 1986-07-07 1987-05-18 Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

Publications (2)

Publication Number Publication Date
DE3788982D1 true DE3788982D1 (de) 1994-03-17
DE3788982T2 DE3788982T2 (de) 1994-05-19

Family

ID=26726151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3788982T Expired - Fee Related DE3788982T2 (de) 1986-07-07 1987-07-06 Trans-6-[2-(N-heteroaryl)-3,5-disubstituiertes)pyrazol-4-yl)-ethyl] oder -ethenyl]tetrahydro-4-hydroxypyran-2-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung.

Country Status (6)

Country Link
US (1) US4808621A (de)
EP (1) EP0252476B1 (de)
JP (1) JPH07116182B2 (de)
CA (1) CA1286671C (de)
DE (1) DE3788982T2 (de)
ES (1) ES2061451T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO881411L (no) * 1987-04-14 1988-10-17 Bayer Ag Substituerte pyrroler.
US4824959A (en) * 1988-02-18 1989-04-25 Bristol-Myers Company Intermediates for antihypercholesterolemic tetrazole compounds
US5026698A (en) * 1988-11-02 1991-06-25 Nissan Chemical Industries, Ltd. Thienopyridine type mevalonolactones
GB8907656D0 (en) * 1989-04-05 1989-05-17 May & Baker Ltd New compositions of matter
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
EP1022270A4 (de) * 1997-01-27 2002-01-30 Daiichi Seiyaku Co Pyrazolderivate
US6169086B1 (en) 1997-01-27 2001-01-02 Daiichi Pharmaceutical Co., Ltd. Pyrazole derivatives
FR2795726A1 (fr) * 1999-06-30 2001-01-05 Aventis Cropscience Sa Nouveaux pyrazoles fongicides
WO2003006439A1 (en) 2001-07-13 2003-01-23 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
CN1545502A (zh) * 2001-08-22 2004-11-10 �������⻯ѧƷ�ع����޹�˾ 吲哚衍生物的制备方法
US20050282883A1 (en) * 2004-04-29 2005-12-22 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7163945B2 (en) * 2004-04-29 2007-01-16 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060084695A1 (en) * 2004-04-29 2006-04-20 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050272770A1 (en) * 2004-04-29 2005-12-08 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7199126B2 (en) * 2004-04-29 2007-04-03 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
CA2590533C (en) 2004-11-23 2010-09-07 Warner-Lambert Company Llc 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
WO2006087630A2 (en) * 2005-02-16 2006-08-24 Warner-Lambert Company Llc OXYPYRAZOLE HMG Co-A REDUCTASE INHIBITORS
US8734705B2 (en) * 2008-06-13 2014-05-27 Tindall Corporation Method for fabrication of structures used in construction of tower base supports
EP2308866A1 (de) * 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375475A (en) * 1979-08-17 1983-03-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
KR890001651B1 (ko) * 1984-06-22 1989-05-12 산도즈 파마슈티칼스 코포레이션 메발로노락톤의 피라졸 동족체 및 이의 유도체의 제조방법
DE3528753A1 (de) * 1985-08-10 1987-02-19 Bayer Ag Substituierte pyrazolin-5-one

Also Published As

Publication number Publication date
ES2061451T3 (es) 1994-12-16
EP0252476B1 (de) 1994-02-02
US4808621A (en) 1989-02-28
EP0252476A3 (en) 1989-10-18
CA1286671C (en) 1991-07-23
EP0252476A2 (de) 1988-01-13
DE3788982T2 (de) 1994-05-19
JPS6388179A (ja) 1988-04-19
JPH07116182B2 (ja) 1995-12-13

Similar Documents

Publication Publication Date Title
DE3788982D1 (de) Trans-6-[2-(N-heteroaryl)-3,5-disubstituiertes)pyrazol-4-yl)-ethyl] oder -ethenyl]tetrahydro-4-hydroxypyran-2-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE69210067D1 (de) Hydraxamsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69017479D1 (de) Azabicycloheptenderivate und ihre Salze, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen.
DE3784478D1 (de) Benzopyran-verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
DE69019550D1 (de) Piperidin-Derivate, ihre Herstellung und ihre Verwendung.
DE69016125D1 (de) Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
DE3885534D1 (de) Arylphosphorderivate, ihre Herstellung und Verwendung.
DE58908176D1 (de) Chinacridon-Pigmente, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE3686677D1 (de) Isoxazol- und furanderivate, verfahren zu ihrer herstellung und ihre verwendung als antivirale mittel.
DE69108356D1 (de) Hydrazonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE69204806D1 (de) 1-Cyanomethyl-4-carboxymethyl-3-ketopiperazine, ihre Salze und Verfahren zu ihrer Herstellung.
DE3586324D1 (de) Tetrahydrophthalimidderivate, verfahren zu ihrer herstellung und ihre verwendung.
DE58908507D1 (de) Neue 10-Ring-Lactone, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE3673734D1 (de) Xanthinderivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DE58907888D1 (de) Neue Polysaccharide, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE58908363D1 (de) 3(2H)-Pyridazinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen.
DE59800568D1 (de) Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3769518D1 (de) N-1h-tetrazol-5-yl-(5-ring)-carboxamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
DE58903567D1 (de) (hetero)aryloxynaphthalinderivate, verfahren und neue (hetero)aryloxynaphthylamine zu ihrer herstellung sowie ihre verwendung als herbizide.
DE59005654D1 (de) Herbizide Sulfonylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE58907707D1 (de) Pastenförmige Pigmentpräparationen, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE58908492D1 (de) Phenoxyalkylsubstituierte Heteroaromaten, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel.
DE59108884D1 (de) Triphendioxazinverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3768416D1 (de) Iminooxazolidine, verfahren zu ihrer herstellung und ihre verwendung.
DE69021127D1 (de) Polyisocyanatoalkylphenyl-isocyanurates, Verfahren zu deren Herstellung und deren Verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee